Lexington Biosciences Inc. (LXGTF)

[StockBro75]

Now that they have officially engaged Diabalo to conduct the clinical trials, we don't have to be so speculative about the actual time to market. We know the average time for a cardiovascular device from the commencement of trials to FDA clearance is 6 months when in the 510K program like LXGTF is. Sounds like they could be announcing FDA clearance around next April, then market and revenues would be right around the corner.